Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ahh whoops, you are completely correct Shandy - screen I was looking at made that an easy mis-interpret!
Great summary BumbleHum but your comment re GBs recent share purchase is incorrect.
When the market crashed in March GB did buy - at c0.83p per skin share - so 8p now in DVRG.
He also contributed in the last fundraise at 1.5p - so now 15p.
He does have loads of shares but none were purchased anywhere near 83p.
Keep up the good work - we need some positivity!!
@Paul - I couldn't help but wince for you as I trawled through RNS's last night I must admit.
There must be a feeling of wishing you'd waited to buy in at this dip...but who knew this is where we'd be! Crazyness.
You wouldn't be alone in that thought if so, or in having a twinge of regret not top slicing and buying more back in lower!
But cest la vie - we are where we are, and it is what it is as they say :-)
I have faith our deflation will turn to elation soon enough :-D
@NewUncle -Indeed.
Whilst the demand for testing is so huge and all the various tests being produced will certainly still have their place - I just can't envisage any of the other tests I've read about, working half as well as Mictotox as an end to end solution. And from a consumer point of view - way better than a nose swab or using blood or spitting in a cup lol.
INNOVA SARS-CoV-2 Antigen Rapid Qualitative Test MONTHLY SUBSCRIPTION
from 693.00 every month
All shipping to UK only.
These are rapid lateral flow tests. They generate accurate results, usually within 15 minutes. This Antigen test has 100% specificity, 98.98% overall accuracy.
Works with nose or throat swab, sputum, or saliva collection by cheek scrape or spitting into a cup
No machine or lab required to process the test.
No cold storage required. Store between 2 and 30 degrees Centigrade.
Please read and comply with the instructions for use (IFU)
CE certified and MHRA registered
We recommend test be conducted only by those medically qualified to do so, using the same PPE worn when conducting a PCR test.
Dispose of used test components according to the IFU.
Your order is placed on the basis that this test is currently scheduled to ship to you in the delivery window commencing October 15th, 2020 to November 15th, 2020
Tests done at your office or at our Clinic by our practitioners. Test for the SARS-CoV-2 coronavirus Antigens. Only £ 199. Next Day Results. Types: RT-PCR, 24 Hours, Open till 6PM.
Look at what one clinic is currently charging for a single test, if nothing else, our system should at least help stop people having to pay these kind of charges:
Coronavirus Rapid 15 Minute Antigen Test - Current Infectiousness
If you need to know quickly if you or your family are likely to be infecting anyone with Covid-19 then this is the test you need. Since this test result comes with a doctors certificate it can be also used as a fit to fly to countries like Italy , Romania etc where an antigen test is sufficient (Signed by a doctor) With reliable results available in 15 minutes this test transforms our community's ability to stop the spread of Covid-19. Perfect for workplaces, film sets, care workers, and any other situation where it is important to know right now whether people are going to be spreading Covid-19. The Abbott’s Panbio Antigen Rapid Test that we provide has shown a 98.2% sensitivity in detecting viral levels that are currently considered to be infectious (Ct values < 33). It has an overall sensitivity and specificity agreement with RT-PCR results of 97.9%.
A positive antigen result should be confirmed with an RT-PCR swab test which we can also do for you with results available late the following evening. This test must be performed by a trained healthcare professional so home testing kits are not available but you can book into any of our locations to have this test done right now.
How does it work: You come to us or one of our trained healthcare professionals come to you. We take a swab from your nose, process the test then and there and send you your results by email. All potentially done within 15-20 minutes.
Your results: You will be told you results as soon as they are available and will have a certificate sent to you by email at the time of your test.
Still plenty to aim for, see latest UK Govt contract award today:
Provision of Innova SARS-CoV-2 Antigen Rapid Qualitative Test Kits
A Contract Award Notice by DEPARTMENT OF HEALTH AND SOCIAL CARE Value USD138M 19 Oct 2020
Concepts diagnostic supplies uk covid-19 testing strategy lateral flow kits provision of innova sars-cov-2 antigen rapid qualitative test kits provision of lateral flow antigen test kits consumables
I hear you Paul,
SKIN (DVRG) and TILs were the first 2 companies i invested in in my ISA for long term (so been through tis with both)
to be fair, when i invested in DVRG at 1.9p (now avg 2.23) for its Labskin innovation (which is going to an industry changer for sure) and water detection, (pre covid)my expectations would be that it would double in 12 months, so its still within my old expectations :)
i am LTH not letting go of any shares, IMO this company will come back stronger with its team and technology
GLA
BumbleHum, I've drawn a conclusion from your comments about trufflehound; buy when they're posting, and sell a couple of weeks later at 10-20% up.
“ A short-term investing mindset also feeds our natural tendency to make emotional decisions when the market is volatile. This can cause us to buy when the market is up and sell when the market is down.”
Spot on NU ! Agree with that comment.
Fwiw. Investing is a long-term game. Many new investors have turned to the stock market as a way to make quick profits during the pandemic. Trying to make profits in the short term can backfire, and investing in a diversified portfolio helps to reduce the ups and downs of individual stocks.
A short-term investing mindset also feeds our natural tendency to make emotional decisions when the market is volatile. This can cause us to buy when the market is up and sell when the market is down.
BumbleHum, good to be reminded while we are all here.
Thanks Gidget :-)
And Thanks Andy - it's a Gem of a company in my opinion...
"With the help of artificial intelligence firm Rinocloud, which it bought in April, Integumen is building Labskin-on-a-chip, which will record every treatment tested on the platform and store its effects in a database.
That will give every dermatology clinic with a computer the ability to take a swab of a patient’s own skin bacteria, place it on the Labskin platform, run it against the database, and advise what the best course of treatment might be.
Then there’s Labskin AI, a digital extension to the lab-grown skin to clone the skin of volunteers in clinical trials.
The company said the new test would cut the number of volunteers required for trials by 50%, reducing recruitment times and project management costs"
(taken from proactive investors Sept article)
...some lovely growth drivers there!!
This is all I'll say in response to you Truffle...
From the 24th Sept to 29th Sept the SP dropped from 40p to 34p. In that period, you appeared on the board to post 23 negative comments.
Then we had a few days where the SP was at 31.5p on the 6th Oct, 26.75p on the 7th Oct, and back up to 30p on 8th Oct - you popped in briefly to post 3 negative comments on the 7th then disappeared again.
Then most recently, the SP has gone from 30.5p on the 13th to where we are now at 26p - and you've come to visit us again with 26 negative comments.
I'm sure people will draw their own conclusions from that.
AIM is full of investors who know the cost of everything, but the value of nothing.
It has, SP is higher than it was 6 months ago and certainly higher than when GB took over.
As a LTH I don't watch SP on the weekly basis. I will agree regarding market agreement/disagreement when at least 6 months are gone from the moment of the sell off. Too early to come to that conclusion after few weeks. Daily and weekly chart analysis tells me that we are in consolidation period.
Lots ofs of LTH of some blue chip companies are happy with 5-10% increase per year. Thats a fairly realistic average expectation.
It seems that lockdown brought in too many new ill researched people with the ideas that this business (investing that is) can bring 2000 % per year all the time.
It can happen to some stocks indeed, but more often than not reality brings those folks back to earth. Majority lose money and quit blaming CEOs, shorters and market makers.
Andy, "the world has moved on", unfortunately the
market hasn`t!
Negative posts with back ups are good
Positive posts with back ups are good
Its silly rampers (who promise £1 bln mcap in 3 weeks) and moany derampers ( who just constantly cry about paper loss) I have problems with.
Its good to critise when things go wrong and point out what happened and how it could have been mitigated.
Last 2 contract RNS' have shown that CEO taken on board comments regarding hints and ramping, and just simply delivered contracts and set time scales on further tests.
Whats the point of constantly revisiting those points with cries aka "we will never forget", when the world has moved on?
Andy, don`t you read properly, I said I kept a few on the offchance,
as for blaming shorter`s, not me, I admire anyone who can make
money in the markets, I think that was your friend Bumble, as for
saying leave this board for holders to discuss, I`m guessing you
mean people with the same opinion as you, so in your little world
no negative posters allowed, I think you should set up a new board
with like minded holders, I`m sure Chesh can help you with that!
Honestly, I don't really care. If you are not a holder, then please leave this board for holders to discuss.
This is a stock market, there is no guarantees, no one owns anything to anyone. Even if you invest in Coca-Cola, there is still a risk that the company might collapse. I couldn't care less about other peoples money lost after being invested during FOMO (I topped up during the same period as well). Market has no soul and doesn't care.
I just prey on institutions to take more shares to their sticky hands out of twitchy PIs who can't sit on their hands and can only hold for 5 minutes.
What I do know is that when SP goes up again, lots of derampers will disappear until SP goes down and I will be reading same crap of someone blaming CEO, shorters, political unrest, weather and other stuff.
This is happening daily for the last 200+ since stock market was invented.
I have been invested in other companies, where there was a total silence from BOD, and guess what, people are demanding hints and more openness towards investors. Its a lose-lose situation for BOD and you can't please everyone.
If you want to see answers from BOD, please refer to investors relations section on companies website.
Andy, first of all, not bitter, sold most of my holdings on the
23rd, day before the presentation, made a few grand, kept
a few on the offchance, he actually might unvail something
substantial, he didn`t!
The share price would never have got to 50`s-60`s-70`s,
without GB`s hyping, a little ambiguous tweet here, litte hint
there, little puzzles, all helped to fuel expectation, a lot of good
hardworking people put their hard earned cash into this company
on the back of what was inferred, that`s what annoys me, and it
shouldn`t be forgotten!
Truffle, you still sound very bitter.
If you lost faith in the company and what happened goes against your investment case, then sell and move on.
I cant remember CEO promising something he didn't deliver. He gave hints, people have interpreted them in their own ways.
CEO did present new product and announced new partner in the name of Dell. He also confirmed ongoing NDA, so at this stage cant elaborate more.
2 new contracts in the last few weeks. Not many biotech startups have revenues coming in, deepverge isn't one of them.
Bumble compared Deepverge to NCYT purely on the basis of share fluctuations. I think this is pretty obvious.
Andy, "forgot the fundamentals of this great company"
I don`t think anyone has forgotten what was on our
CEO`s promise list, different word from fundamentals.
As for Bumble comparing our prospects with NCYT, the
reason that company has acheived stellar gains are down
to substantial contract wins, we`re talking 100mil contracts,
when DV can show some of the same, then perhaps the market
will take the company seriously, until then we are just another
company that might ....have prospects!
What a fantastic reminder, BumbleHum.
No ramping, just pure facts and backed up research.
Its a shame such posts can't be pinned on LSE board.
Lots of people have developed a tunnel vision lately and completely forgot the fundamentals of this great company.
prospects. It might not be profitable YET - but neither was Amazon for years! Revenues have increased though, and as Bezos
has long maintained, Investing in future growth is more important than hitting quarterly earnings targets!
But with all the exciting stuff going on with Deepverge at the moment, with multiple revenue streams opening
up - it's only a matter of time!
Deepverges new business strategy also led to the collaboration and then acquisitions of modern water.
Here's a reminder of that water-shed (teehee) moment...
https://www.**********.co.uk/articles/modern-water-signs-3-year-revenue-sharing-agreement-with-integumen-to-fulfil-us-0-7m-of-backorders--dab8427/
This has also been a genius move that has led to the growth of new business opportunities from real time
water contamination detection, with RAWTest AI system to be retrofitted to Modern Waters Microtox Units being rolled
out, and the development of the Microtox Breath Test.
As part of the DRAWQ (Detroit River AI Water Quality) project, an MOU has been signed for Deepverge to supply
equipment, consumables & services, and manage the real time monitoring.
It has been stated that the Water Rising institute intends to then help spread this solution to other parts of the US and
world.
As for the breath test - the first round of testing was successfully completed, and it is currently being tested
on real Covid samples at the Uni of Aberdeen, with results anticipated by year end.
With public health sector testing capacity strained, private test providers have reported a massive surge in
demand!
BAE contracted Circular health to mass test its workforce in a pop up lab on site.
Bupa has been providing 750 organisations in the UK with tests.
Private equity firms, law firms and investment banks have been buying tests from private Harley St Clinic in London.
English Premier League hired Prenetics to test players and staff one a week (Big % of their 16mill Pandemic spend
was on its testing regime).
London Med Lab said demand for their PCR tests has risen from 100 to 1000/day (Its PCR test costs £149).
The Drs lab (largest test processor in the uk after the gov's lighthouse labs) has had to tell customers it
has reached full capacity.
The demand from businesses for a rapid covid test is huge, and companies have got the ££ to spend if it means they
can open doors again!
There are lots of various rapid tests out there awaiting approvals, but I really don't see any that are as good
as Deepverges.
The Digital health platform that underpins the Microtox BT is what sets it above most of the competition IMO.
Although the market for testing is massive, plenty of pie for everyone!
Here's an interesting read if you missed it at the time...
https://www.dailymail.co.uk/news/article-8759063/Public-PAY-rapid-Covid-19-tests-promised-Moonshot-plan.html
What I like in particular about the Microtox BT though is that the software is agnostic and could be used
for other viruses. And the Test itself can be adapted by interchanging the binders to capture other viruses.
So there's future growth/opportunity there to produce chips that could detect other viruses, not just Covid.
Which is pretty cool!
Deepverge is a high quality, early-stage, disruptive biotech growth company with increasing pipeline activity
and solid
And this is where it gets exciting! Deepverges Labskin imitates the real human skin biome, and is the only
commercially available 'off the shelf' Lab grown-full thickness-human skin model, with an AI assisted
testing platform.
Integumens change of business direction and acquisition of Rinocloud was genius. Integumens
years of developing skin models, and RinoClouds AI savvy-ness, have resulted in a phsyical and digital testing combination
that has already led to new customers and initial orders.
The unrivalled AI driven repository of data and knowledge is in continuous development. Algorithms are applied
to data sets of 12 years of tests carried out in labskin labs, and data from both publicly available and exclusive
data sources, including scientific literature, patents, clinical trials, disease symptoms, drug targets, skincare
formulations and chemical structures.
The AI has then been able to create a virtual skin model!
Rather than companies testing physical skin - they can test them online, with the AI models able to suggest improvements.
This allows companies to narrow down their list of formulations to a short list to then be tested on real skin.
This has accelerated the original process of elimination time from 18 months to 10 minutes!
Labskin have also just recently launched the worlds first remote clinical skin trials platform!
Which means clinical trials can continue remotely, and with data and analytics from AI diseased skin models, has
the ability to transform the R & D process of skin treatments, making them cheaper and brought to market quicker.
Deepverges STOER skincare products are used as a control range of products that offer Labskin clients
proof of concept for their products to be tested. Notably - was completion of test protocols for the inclusion
of CBD in client products! This is a massive (multi billion dollar) growing market for the anti-inflammatory
and pain relief properties.
All very exciting stuff! The Labskin side of the business has grown in leaps and bounds, and I think it will perform
outstandingly well in this emerging biotech market.